Toromont Announces 2021 Results and Quarterly Dividend

Written by Customer Service on February 9, 2022. Posted in Public Companies.

TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Toromont Industries Ltd. (TSX: TIH) today reported financial results for the three months and year ended December 31, 2021. Three months ended December 31 Years ended December 31 millions, except per share amounts 2021 2020 % change 2021 2020 % change Revenues $ 956.0 $ 992.2 (4 %) $ 3,886.5 $ 3,478.9 12 % Operating income $ 148.8 $ 127.2 17 % $ 475.9 $ 372.4 28 % Net earnings $ 105.6 $ 89.0 19 % $ 332.7 $ 254.9 31 % Basic earnings per share (“EPS”) $ 1.28 $ 1.08 19 % $ 4.03 $ 3.10 30 % “Toromont delivered solid results in the fourth quarter and full year of 2021, reflective of our focus on operational execution and favourable operating leverage, including the benefit...

Computer Modelling Group Announces Chair of the Board Retirement and Succession

Written by Customer Service on February 9, 2022. Posted in Public Companies.

CALGARY, Alberta, Feb. 09, 2022 (GLOBE NEWSWIRE) — The Board of Directors of Computer Modelling Group Ltd. (“CMG” or the “Company”) today announced that John Zaozirny, Chair of the Board of Directors, has retired from the Company’s Board of Directors effective February 9, 2022 in accordance with his plans to retire. Mark Miller, a current independent director of the Board, will succeed Mr. Zaozirny as Board Chair. Mr. Zaozirny was first appointed to CMG’s Board of Directors in 1996 and appointed as the Board Chair in 2017. He has had a distinguished career as a director and advisor of a number of public and private corporations. He is a former Alberta Minister of Energy, having served in the Alberta Legislature from 1979 to 1986. He was awarded the designation of Queen’s Counsel in 1984, and named Resource Man of the Year by the...

Medexus Pharmaceuticals Generated $21.3M in Fiscal 2022 Third Quarter Revenues and Achieved $1.9M Positive EBITDA for the Three Months Ended December 31, 2021

Written by Customer Service on February 9, 2022. Posted in Public Companies.

Achieved $21.3 million revenue driven by a recovery in IXINITY sales Treosulfan NDA resubmission expected in second calendar quarter 2022 with final FDA decision anticipated 2-6 months after resubmission Available liquidity of $10.1 million at end of period Management to host conference call at 8:00 AM Eastern Time on February 10, 2022 TORONTO and CHICAGO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) today announced its financial results and provided a business update for the three-month period ended December 31, 2021. All dollar amounts below are in United States dollars unless specified otherwise. Third Quarter Fiscal 2022 Financial Highlights: Revenue of $21.3 million, an increase of 19% compared to $17.9 million in Q2 of fiscal 2022 and a 12% decrease...

Statera Biopharma Announces Closing of $2.0 Million Registered Direct Offering

Written by Customer Service on February 9, 2022. Posted in Public Companies.

FORT COLLINS, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced the closing of its previously announced registered direct offering with a certain institutional investor, pursuant to which the Company sold $2.0 million worth of its common stock and warrants. Under the terms of the securities purchase agreement, the Company sold approximately 2.0 million shares of its common stock and warrants to purchase approximately 2.0 million shares of common stock. The warrants will be exercisable immediately, have an exercise price of $1.00 per share, and will expire five years from the initial exercise date. The purchase price for...

Growth Capital Acquisition Corp. Announces Stockholder Approval of Business Combination with Cepton Technologies, Inc.

Written by Customer Service on February 9, 2022. Posted in Mergers And Acquisitions.

NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) — Growth Capital Acquisition Corp. (NASDAQ: GCACU, GCAC and GCACW) (“Growth Capital or “GCAC”), a special purpose acquisition company, today announced that its stockholders have voted to approve the proposed business combination (the “Business Combination”) with Cepton Technologies, Inc., a developer of lidar-based solutions for automotive (ADAS/AV), smart cities, smart spaces and smart industrial applications (“Cepton”) at its special meeting of stockholders (the “Special Meeting”) held today, February 9, 2022. Holders of approximately 72.94% of Growth Capital’s issued and outstanding shares cast votes at the Special Meeting. Approximately 93.82% of the votes cast at the Special Meeting voted to approve the Business Combination. In light of receipt of the requisite approvals by Growth Capital’s...

Clearmind Medicine announces Share-Based Compensation Plan

Written by Customer Service on February 9, 2022. Posted in Public Companies.

TORONTO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTCMKTS: CMNDF) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, announces today that on February 1, 2022 the company approved, pursuant to the Option Plan, 2,020,000 Options an exercise price no lower than $0.56. Of these 1,500,000 options are to company Directors and Officers. In addition, the company authorized the issuance of 60,000 RSUs/month for a 24 month period to 3 company consultants. The agreements with the 3 consultants may be terminated by CMND, at anytime prior to the expiry date without prior notice or cause (such termination an “Accelerated Termination”)....

Monarch Reports Its Results for the Second Quarter Ended December 31, 2021

Written by Customer Service on February 9, 2022. Posted in Public Companies.

MONTREAL, Feb. 09, 2022 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) reported its results today for the second quarter ended December 31, 2021. Amounts are in Canadian dollars unless otherwise indicated. Summary of financial results (In dollars, except per share data) Quarter endedDecember 31,2021 Six months endedDecember 31,2021 Administrative expenses (2,374,268 ) (4,289,297 ) Exploration expenses (714,471 ) (2,444,166 ) Gain on disposal of assets – 7,690,483 Deferred income and mining taxes 732,437 (1,008,289 ) Net earnings (loss) (2,060,446 ) 782,928 Net earnings (loss) per share, basic and diluted (0.03 ) 0.01 (In dollars) As at December 31,2021 Cash and cash equivalents 18,920,581 Restricted cash (1) 6,000,000 Total assets 98,334,050 1) Not...

Home BancShares, Inc. Ranked #1 For a Third Time on Forbes List of Best Banks in America

Written by Customer Service on February 9, 2022. Posted in Public Companies.

CONWAY, Ark., Feb. 09, 2022 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NYSE: HOMB) (“the Company”), parent company of Centennial Bank, has been ranked #1 on the Forbes 2022 “Best Banks in America” list for the third time. The Company also achieved the top ranking in 2018 and 2019. This is the thirteenth consecutive year Forbes has ranked America’s largest banks, using financial data from S&P Global Market Intelligence. “Being ranked #1 Bank in America by Forbes is quite an honor, but to be ranked #1 three times out of the last five years (two years back to back) makes me ecstatic. Our bankers work hard for our customers and shareholders and it’s rewarding to see their efforts recognized,” said John Allison, Chairman, CEO and President. Home BancShares scored in the top-50 for every metric, and in the top-10 in five of the nine...

Andrew Peller Limited Reports Results for Third Quarter Fiscal 2022

Written by Customer Service on February 9, 2022. Posted in Public Companies.

GRIMSBY, Ontario, Feb. 09, 2022 (GLOBE NEWSWIRE) — Andrew Peller Limited ADW.A/ADW.B (“APL” or the “Company”) announced today its results for the three and nine months ended December 31, 2021. FISCAL 2022 HIGHLIGHTS: Year-to-date sales decreased by 6.0% when compared to the prior year due to temporary COVID related shifts in purchasing patterns over the past two years; Gross margin decreased to 39.3% for the nine months ended December 31, 2021 compared to 40.9% in prior year due to an increase in import wine and other global supply chain costs as a result of COVID-19; Selling and administration expenses increased as previously furloughed staff returned to work and marketing costs have increased compared to fiscal 2021; Sale of Port Coquitlam property generates realized gain of $7.5 million ($0.21 per Class A Share); and 10% increase...

Shattuck Labs Announces Participation in Upcoming 11th Annual SVB Leerink Global Healthcare Conference

Written by Customer Service on February 9, 2022. Posted in Public Companies.

AUSTIN, TX and DURHAM, NC, Feb. 09, 2022 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease with three ongoing Phase 1 clinical trials, today announced that company management will participate in the 11th Annual SVB Leerink Global Healthcare Conference being held February 14-18, 2022. Presentation Details Conference: 11th Annual SVB Leerink Global Healthcare Conference Format: Corporate Presentation Presenter: Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive Officer Date: February 18, 2022 Time: 10:40 a.m. EST A live webcast of the presentation will be available on the Events & Presentations section...

Day: February 9, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice